Asthma Drug Interactions in Patients Pediatric Inpatient Hospital X Jakarta

  • Mochamad Prasetyo Hardadi Study Program of Public Health Science, the Graduate School, University of Muhammadiyah Prof. Dr. HAMKA, Jakarta, Indonesia
  • Fatimah Fatimah General Hospital of Pengayoman, Indonesian Ministry of Law and Human Rights, Jakarta, Indonesia

Abstract

Asthma is a chronic disorder of the airways that is characterized periods of airflow obstruction. Asthma medication use in pediatrics is often encountered various problems. This study aims to determine the potential for drug interactions in pediatric asthma patients hospitalized in the Hospital X Jakarta period January 2015 to April 2017. This type of research is retrospective descriptive and analysis using the chi-square test. Retrieval of data through medical records with total sampling method. Based on the results of the study concluded that there are potential drug interactions of 31 patients (28.18%) and there are 48 cases of interaction. The most type of interaction mechanism is pharmacodynamic interaction in 33 cases (68.75%). The highest severity of interactions was moderate interactions in 40 cases (83.33%), and the highest onset of interactions was delayed onset of 32 cases (66.67%). The results of the chi-square analysis are shown from the probability value of 0.0000 (p-value <0.005), it can be concluded that there is a relationship between the amount of drug administration in a prescription with a significant drug interaction, and the results of the ods ratio indicate that the patient receiving the number of prescriptions in the drug ≥ 5 amounted to 0.244 times higher than the drug interactions that occur.

Author Biography

Mochamad Prasetyo Hardadi, Study Program of Public Health Science, the Graduate School, University of Muhammadiyah Prof. Dr. HAMKA, Jakarta, Indonesia
MPH Student

References

CDC's National Asthma Control Program Grantees. 2013. Asthma Facts. US Department of Health and Human Services Centers for Disease Control and Prevention. P. 1-15.

Darmila AR. 2012. Relationship Characteristics Bronchial Asthma Patients With Symptoms Gastroesophageal reflux disease (PRGE) In hospitals DR. Soedarso Pontianak. Publication manuscript. Medical Education Program Faculty of Medicine, University of Tanjongpura Pontianak. P. 1-20.

Ministry of Health. 2009. Pharmaceutical Services Guidelines For Patients Pediatrics. Jakarta: Directorate of Community and Clinical Pharmacy Directorate General of Pharmacy and Medical Equipment, Ministry of Health. P. 1-25.

Dewi CAK, Athiyah U, Mufarrihah, Nita Y. 2014. Drug Therapy Problems In Patients Who Receive Polypharmacy Recipe (Studies in Pharmacy Pharmacy Airlangga). Journal of Community Pharmacy Vol. 1, No. 1, (2014). P. 17-22.

Interactions Checker. www.drugs.com , Retrieved on March 14, 2017 - October 10 2017.

Ministry of Health. 2013. Basic Health Research. Research and Development of Health, Ministry of Health. P. 85-87

Ministry of Health. 2015. You Can Control Your Asthma. Data Center and Information Ministry of Health, Ministry of Health. P. 1-7.

Mangguang MDT. 2016. Risk Factors Genesis Asthma in Children in Padang. Arc. Com. Health, Vol. 3 No. 1: 1-7. P. 2-6.

Mariam S. 2016. Evaluation of Drug Interaction Genesis Inpatient Geriatric Patients Patients with Heart Failure. Journal Farmamedika, Vol. 1. No. 1. Pg. 1-6.

Nursanti F. 2016. Potential Drug Interaction Study In Pediatric Patients Prescription Retrospective at 3 pharmacies Surakarta period from July to December, 2014. Publication manuscript. Faculty of Pharmacy UMS, Surakarta. P. 1-12.

Setyorini N. 2016. Potential Drug Interactions in Patients Asthma Hospitalization In RS X Year 2014. Publication manuscript. Faculty of Pharmacy UMS, Surakarta. P. 1-15.

Tatro DS. 2014. Drug Interaction Facts, The Authority On Drug Interactions. Facts & Comparisons: Wolters Kluwer Health, Inc.

Published
2020-09-07
How to Cite
Hardadi, M. P., & Fatimah, F. (2020). Asthma Drug Interactions in Patients Pediatric Inpatient Hospital X Jakarta. JUMP Health (Journal of Ultimate Public Health), 4(1), 262-269. https://doi.org/10.22236/jump-health.v4.i1.p262-269
Section
Articles